What a stupid comment.
Just bought in more at 8.7c
Some people just don't understand its a med stock. Without the approvals, never going to be successful. However, they have FDA approvals on 2 products. The IPO was priced amazingly high. Sell off occurs all the time for profits and when the FDA approvals originally didn't occur, SP tanks. FDA approval received and boom, 1700% gain. Sell off for profits as anyone would on that. Levelled out to .10c and fluttered for 6 months there awaiting further updates.
CR at 7c during this time, needed but annoying. Up to 10.5 over the next month - anyone would sell and take profits. Retrace inevitable for another leg up. Look at the chart history.
Unexpected deal and pending news on distribution and revenues. $150,000 in 2 weeks for Viradx. $14M in Hologic deal. They will make positive gains in revenue this FY compared to last only making $10M. If costs from last year are any indication, then this year they could turn or be close to turning profits.
They have had an existing pipeline for the product with McKesson and Cardinal etc via Status (Viradx). Wouldn't be surprised if there are on the updates on this incoming.
What a stupid comment.Just bought in more at 8.7cSome people...
Add to My Watchlist
What is My Watchlist?
